Literature DB >> 9087202

Esophageal cancer. Clinical and pathologic features.

R M Gore1.   

Abstract

Carcinoma of the esophagus remains one of the most lethal of all cancers. In the past, squamous cell carcinomas accounted for over 95% of esophageal malignancies. Over the past two decades, however, there has been a dramatic increase in the incidence of adenocarcinoma arising in columnar cell-lined Barrett's mucosa, accounting for up to 34% of all esophageal cancers in some areas. This article discusses the different demographic, pathologic, therapeutic, and prognostic features of squamous cell and adenocarcinoma of the esophagus.

Entities:  

Mesh:

Year:  1997        PMID: 9087202

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  5 in total

Review 1.  Investigation and management of chronic dysphagia.

Authors:  Paula Leslie; Paul N Carding; Janet A Wilson
Journal:  BMJ       Date:  2003-02-22

2.  Modulation of integrin-linked kinase (ILK) expression in human oesophageal squamous cell carcinoma cell lines by the EGF and TGFbeta1 growth factors.

Authors:  Glenn A Driver; Robin B Veale
Journal:  Cancer Cell Int       Date:  2006-04-27       Impact factor: 5.722

3.  A retrospective review of the prognostic value of ALDH-1, Bmi-1 and Nanog stem cell markers in esophageal squamous cell carcinoma.

Authors:  Cheng-Cheng Hwang; Shin Nieh; Chien-Hong Lai; Chien-Sheng Tsai; Liang-Che Chang; Chung-Ching Hua; Wen-Ying Chi; Hui-Ping Chien; Chih-Wei Wang; Siu-Cheung Chan; Tsan-Yu Hsieh; Jim-Ray Chen
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

4.  Imaging of esophageal cancer.

Authors:  R Iyer; R Dubrow
Journal:  Cancer Imaging       Date:  2004-09-09       Impact factor: 3.909

5.  Redistribution of β-catenin in response to EGF and lithium signalling in human oesophageal squamous carcinoma cell lines.

Authors:  Lindsay Jg Jones; Rob B Veale
Journal:  Cancer Cell Int       Date:  2003-08-15       Impact factor: 5.722

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.